AIDS - Boosting immunity to HIV - Can the virus help?

被引：42

作者：

Autran, B ^{[1
]}

Carcelain, G ^{[1
]}

机构：

[1] Hop La Pitie Salpetriere, Lab Immunol Cellulaire & Tissulaire, F-75013 Paris, France

来源：

SCIENCE | 2000年 / 290卷 / 5493期

关键词：

D O I：

10.1126/science.290.5493.946

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：946 / +

页数：3

共 12 条

[1]

CARCELAIN G, IN PRESS J VIROL

[2] Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy [J].

Dalod, M ;

Harzic, M ;

Pellegrin, I ;

Dumon, B ;

Hoen, B ;

Sereni, D ;

Deschemin, JC ;

Levy, JP ;

Venet, A ;

Gomard, E .

JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :61-69

[3] TEMPORAL ASSOCIATION OF CELLULAR IMMUNE-RESPONSES WITH THE INITIAL CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SYNDROME [J].

KOUP, RA ;

SAFRIT, JT ;

CAO, YZ ;

ANDREWS, CA ;

MCLEOD, G ;

BORKOWSKY, W ;

FARTHING, C ;

HO, DD .

JOURNAL OF VIROLOGY, 1994, 68 (07) :4650-4655

[4] Control of HIV despite the discontinuation of antiretroviral therapy [J].

Lisziewicz, J ;

Rosenberg, E ;

Lieberman, J ;

Jessen, H ;

Lopalco, L ;

Siliciano, R ;

Walker, B ;

Lori, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1683-1684

[5] Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men [J].

Lyles, RH ;

Muñoz, A ;

Yamashita, TE ;

Bazmi, H ;

Detels, R ;

Rinaldo, CR ;

Margolick, JB ;

Phair, JP ;

Mellors, JW .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :872-880

[6] Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load [J].

Mollet, L ;

Li, TS ;

Samri, A ;

Tournay, C ;

Tubiana, R ;

Calvez, V ;

Debré, P ;

Katlama, C ;

Autran, B .

JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1692-1704

[7] Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection [J].

Murali-Krishna, K ;

Altman, JD ;

Suresh, M ;

Sourdive, DJD ;

Zajac, AJ ;

Miller, JD ;

Slansky, J ;

Ahmed, R .

IMMUNITY, 1998, 8 (02) :177-187

[8] HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment [J].

Neumann, AU ;

Tubiana, R ;

Calvez, V ;

Robert, C ;

Li, TS ;

Agut, H ;

Autran, B ;

Katlama, C .

AIDS, 1999, 13 (06) :677-683

[9] HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy [J].

Ortiz, GM ;

Nixon, DF ;

Trkola, A ;

Binley, J ;

Jin, X ;

Bonhoeffer, S ;

Kuebler, PJ ;

Donahoe, SM ;

Demoitie, MA ;

Kakimoto, WM ;

Ketas, T ;

Clas, B ;

Heymann, JJ ;

Zhang, LQ ;

Cao, YZ ;

Hurley, A ;

Moore, JP ;

Ho, DD ;

Markowitz, M .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06) :R13-R18

[10] Immune control of HIV-1 after early treatment of acute infection [J].

Rosenberg, ES ;

Altfeld, M ;

Poon, SH ;

Phillips, MN ;

Wilkes, BM ;

Eldridge, RL ;

Robbins, GK ;

D'Aquila, RT ;

Goulder, PJR ;

Walker, BD .

NATURE, 2000, 407 (6803) :523-526

← 1 2 →